{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:24:46Z","timestamp":1792801486611,"version":"4.5.0"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:00:00Z","timestamp":1712966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:00:00Z","timestamp":1712966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"University of Innsbruck and Medical University of Innsbruck"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s40263-024-01087-y","type":"journal-article","created":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T08:02:00Z","timestamp":1712995320000},"page":"443-457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Impulse Control Disorders in Parkinson\u2019s Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6909-0150","authenticated-orcid":false,"given":"Federico","family":"Carbone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7174-6000","authenticated-orcid":false,"given":"Atbin","family":"Djamshidian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,13]]},"reference":[{"issue":"8","key":"1087_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s00406-006-0668-0","volume":"256","author":"B Dell'Osso","year":"2006","unstructured":"Dell\u2019Osso B, Altamura AC, Allen A, Marazziti D, Hollander E. Epidemiologic and clinical updates on impulse control disorders: a critical review. Eur Arch Psychiatry Clin Neurosci. 2006;256(8):464\u201375.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1087_CR2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Publishing; 2013.","edition":"5"},{"issue":"4","key":"1087_CR3","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1017\/S1092852916000183","volume":"21","author":"JE Grant","year":"2016","unstructured":"Grant JE, Chamberlain SR. Expanding the definition of addiction: DSM-5 vs. ICD-11. CNS Spectr. 2016;21(4):300\u20133.","journal-title":"CNS Spectr"},{"issue":"8","key":"1087_CR4","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/mdc3.13339","volume":"8","author":"ZQ Kok","year":"2021","unstructured":"Kok ZQ, Murley AG, Rittman T, Rowe J, Passamonti L. Co-occurrence of apathy and impulsivity in progressive supranuclear palsy. Mov Disord Clin Pract. 2021;8(8):1225\u201333.","journal-title":"Mov Disord Clin Pract."},{"issue":"5","key":"1087_CR5","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/mds.22902","volume":"25","author":"SS O'Sullivan","year":"2010","unstructured":"O\u2019Sullivan SS, Djamshidian A, Ahmed Z, Evans AH, Lawrence AD, Holton JL, et al. Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy. Mov Disord. 2010;25(5):638\u201342.","journal-title":"Mov Disord"},{"issue":"6","key":"1087_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.parkreldis.2005.06.005","volume":"11","author":"KJ Klos","year":"2005","unstructured":"Klos KJ, Bower JH, Josephs KA, Matsumoto JY, Ahlskog JE. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson\u2019s disease and multiple system atrophy. Parkinsonism Relat Disord. 2005;11(6):381\u20136.","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"1087_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.parkreldis.2013.12.010","volume":"20","author":"R Cilia","year":"2014","unstructured":"Cilia R, Siri C, Colombo A, Pezzoli G. Multiple compulsive behaviors in multiple system atrophy: the importance of predisposition to addiction. Parkinsonism Relat Disord. 2014;20(3):355\u20137.","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"1087_CR8","doi-asserted-by":"publisher","first-page":"760.e5","DOI":"10.1016\/j.genhosppsych.2014.06.005","volume":"36","author":"S Pompanin","year":"2014","unstructured":"Pompanin S, Jelcic N, Cecchin D, Cagnin A. Impulse control disorders in frontotemporal dementia: spectrum of symptoms and response to treatment. Gen Hosp Psychiatry. 2014;36(6):760.e5-7.","journal-title":"Gen Hosp Psychiatry"},{"issue":"5","key":"1087_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010;67(5):589\u201395.","journal-title":"Arch Neurol"},{"issue":"3","key":"1087_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10899-009-9123-2","volume":"25","author":"AJ Holman","year":"2009","unstructured":"Holman AJ. Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia. J Gambl Stud. 2009;25(3):425\u201331.","journal-title":"J Gambl Stud"},{"issue":"1","key":"1087_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1212\/WNL.0000000000002803","volume":"87","author":"B Heim","year":"2016","unstructured":"Heim B, Djamshidian A, Heidbreder A, Stefani A, Zamarian L, Pertl MT, et al. Augmentation and impulsive behaviors in restless legs syndrome: coexistence or association? Neurology. 2016;87(1):36\u201340.","journal-title":"Neurology"},{"issue":"8","key":"1087_CR12","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s40618-020-01478-0","volume":"44","author":"G Beccuti","year":"2021","unstructured":"Beccuti G, Guaraldi F, Natta G, Cambria V, Prencipe N, Cicolin A, et al. Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study. J Endocrinol Invest. 2021;44(8):1699\u2013706.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"1087_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1176\/appi.neuropsych.10010013","volume":"24","author":"A Wright","year":"2012","unstructured":"Wright A, Rickards H, Cavanna AE. Impulse-control disorders in gilles de la tourette syndrome. J Neuropsychiatry Clin Neurosci. 2012;24(1):16\u201327.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"1087_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.encep.2015.12.013","volume":"42","author":"R Porteret","year":"2016","unstructured":"Porteret R, Bouchez J, Bayle FJ, Varescon I. ADH\/D and impulsiveness: prevalence of impulse control disorders and other comorbidities, in 81 adults with attention deficit\/hyperactivity disorder (ADH\/D). Encephale. 2016;42(2):130\u20137.","journal-title":"Encephale."},{"issue":"5","key":"1087_CR15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3109\/00952990.2010.503823","volume":"36","author":"FD Garcia","year":"2010","unstructured":"Garcia FD, Thibaut F. Sexual addictions. Am J Drug Alcohol Abuse. 2010;36(5):254\u201360.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1\u20132","key":"1087_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jns.2011.07.031","volume":"310","author":"A Djamshidian","year":"2011","unstructured":"Djamshidian A, Averbeck BB, Lees AJ, O\u2019Sullivan SS. Clinical aspects of impulsive compulsive behaviours in Parkinson\u2019s disease. J Neurol Sci. 2011;310(1\u20132):183\u20138.","journal-title":"J Neurol Sci"},{"issue":"5","key":"1087_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/0006-3223(94)90636-X","volume":"36","author":"JH Friedman","year":"1994","unstructured":"Friedman JH. Punding on levodopa. Biol Psychiatry. 1994;36(5):350\u20131.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1087_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/mdc3.13363","volume":"9","author":"P Barbosa","year":"2022","unstructured":"Barbosa P, O\u2019Sullivan SS, Joyce E, Lees AJ, Warner TT, Djamshidian A. Neuropsychiatric features of punding and hobbyism in Parkinson\u2019s disease. Mov Disord Clin Pract. 2022;9(1):82\u20136.","journal-title":"Mov Disord Clin Pract."},{"issue":"2","key":"1087_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mds.22687","volume":"25","author":"SS O'Sullivan","year":"2010","unstructured":"O\u2019Sullivan SS, Evans AH, Quinn NP, Lawrence AD, Lees AJ. Reckless generosity in Parkinson\u2019s disease. Mov Disord. 2010;25(2):221\u20133.","journal-title":"Mov Disord"},{"issue":"8","key":"1087_CR20","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/mds.23016","volume":"25","author":"SS O'Sullivan","year":"2010","unstructured":"O\u2019Sullivan SS, Djamshidian A, Evans AH, Loane CM, Lees AJ, Lawrence AD. Excessive hoarding in Parkinson\u2019s disease. Mov Disord. 2010;25(8):1026\u201333.","journal-title":"Mov Disord"},{"issue":"4","key":"1087_CR21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","volume":"68","author":"G Giovannoni","year":"2000","unstructured":"Giovannoni G, O\u2019Sullivan JD, Turner K, Manson AJ, Lees AJ. Hedonistic homeostatic dysregulation in patients with Parkinson\u2019s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry. 2000;68(4):423\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"24","key":"1087_CR22","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1212\/WNL.0b013e318296e9d5","volume":"80","author":"JH Friedman","year":"2013","unstructured":"Friedman JH, Chang V. Crack cocaine use due to dopamine agonist therapy in Parkinson disease. Neurology. 2013;80(24):2269\u201370.","journal-title":"Neurology"},{"key":"1087_CR23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1146\/annurev-clinpsy-032813-153705","volume":"10","author":"BB Averbeck","year":"2014","unstructured":"Averbeck BB, O\u2019Sullivan SS, Djamshidian A. Impulsive and compulsive behaviors in Parkinson\u2019s disease. Annu Rev Clin Psychol. 2014;10:553\u201380.","journal-title":"Annu Rev Clin Psychol"},{"issue":"2","key":"1087_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/mds.24023","volume":"27","author":"D Weintraub","year":"2012","unstructured":"Weintraub D, Mamikonyan E, Papay K, Shea JA, Xie SX, Siderowf A. Questionnaire for impulsive-compulsive disorders in Parkinson\u2019s Disease-Rating Scale. Mov Disord. 2012;27(2):242\u20137.","journal-title":"Mov Disord"},{"issue":"11","key":"1087_CR25","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/mds.22505","volume":"24","author":"AH Evans","year":"2009","unstructured":"Evans AH, Strafella AP, Weintraub D, Stacy M. Impulsive and compulsive behaviors in Parkinson\u2019s disease. Mov Disord. 2009;24(11):1561\u201370.","journal-title":"Mov Disord"},{"issue":"1","key":"1087_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.tics.2011.11.009","volume":"16","author":"TW Robbins","year":"2012","unstructured":"Robbins TW, Gillan CM, Smith DG, de Wit S, Ersche KD. Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. Trends Cogn Sci. 2012;16(1):81\u201391.","journal-title":"Trends Cogn Sci"},{"issue":"4","key":"1087_CR27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/mds.20045","volume":"19","author":"AH Evans","year":"2004","unstructured":"Evans AH, Katzenschlager R, Paviour D, O\u2019Sullivan JD, Appel S, Lawrence AD, et al. Punding in Parkinson\u2019s disease: its relation to the dopamine dysregulation syndrome. Mov Disord. 2004;19(4):397\u2013405.","journal-title":"Mov Disord"},{"issue":"4","key":"1087_CR28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/jnnp-2016-315277","volume":"88","author":"A Antonini","year":"2017","unstructured":"Antonini A, Barone P, Bonuccelli U, Annoni K, Asgharnejad M, Stanzione P. ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2017;88(4):317\u201324.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"1087_CR29","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1136\/jnnp-2017-317298","volume":"89","author":"PM Barbosa","year":"2018","unstructured":"Barbosa PM, Grippe T, Lees AJ, O\u2019Sullivan S, Djamshidian A, Warner TT. Compulsive sexual behaviour in Parkinson\u2019s disease is associated with higher doses of levodopa. J Neurol Neurosurg Psychiatry. 2018;89(10):1121\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"13","key":"1087_CR30","first-page":"59","volume":"101","author":"A Barbeau","year":"1969","unstructured":"Barbeau A. L-dopa therapy in Parkinson\u2019s disease: a critical review of nine years\u2019 experience. Can Med Assoc J. 1969;101(13):59\u201368.","journal-title":"Can Med Assoc J"},{"issue":"12","key":"1087_CR31","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1176\/ajp.127.12.1691","volume":"127","author":"MB Bowers Jr","year":"1971","unstructured":"Bowers MB Jr, Van Woert M, Davis L. Sexual behavior during L-dopa treatment for Parkinsonism. Am J Psychiatry. 1971;127(12):1691\u20133.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1087_CR32","first-page":"58","volume":"56","author":"SK Shapiro","year":"1973","unstructured":"Shapiro SK. Hypersexual behavior complicating levodopa (I-dopa) therapy. Minn Med. 1973;56(1):58\u20139.","journal-title":"Minn Med"},{"key":"1087_CR33","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jns.2016.07.003","volume":"368","author":"L Vela","year":"2016","unstructured":"Vela L, Martinez Castrillo JC, Garcia Ruiz P, Gasca-Salas C, Macias Macias Y, Perez Fernandez E, et al. The high prevalence of impulse control behaviors in patients with early-onset Parkinson\u2019s disease: a cross-sectional multicenter study. J Neurol Sci. 2016;368:150\u20134.","journal-title":"J Neurol Sci"},{"issue":"3","key":"1087_CR34","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1212\/WNL.0000000000005816","volume":"91","author":"JC Corvol","year":"2018","unstructured":"Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, et al. Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology. 2018;91(3):e189-201.","journal-title":"Neurology"},{"issue":"6","key":"1087_CR35","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/mdc3.13276","volume":"8","author":"P Rabano-Suarez","year":"2021","unstructured":"Rabano-Suarez P, Martinez-Fernandez R, Natera-Villalba E, Parees I, Martinez-Castrillo JC, Alonso-Canovas A. Impulse control disorders in Parkinson\u2019s disease: has COVID-19 related lockdown been a trigger? Mov Disord Clin Pract. 2021;8(6):940\u20133.","journal-title":"Mov Disord Clin Pract."},{"issue":"7","key":"1087_CR36","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","volume":"67","author":"V Voon","year":"2006","unstructured":"Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology. 2006;67(7):1254\u20137.","journal-title":"Neurology"},{"issue":"6","key":"1087_CR37","first-page":"242","volume":"55","author":"SL McElroy","year":"1994","unstructured":"McElroy SL, Keck PE Jr, Pope HG Jr, Smith JM, Strakowski SM. Compulsive buying: a report of 20 cases. J Clin Psychiatry. 1994;55(6):242\u20138.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"1087_CR38","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/ana.22356","volume":"69","author":"V Voon","year":"2011","unstructured":"Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, et al. Impulse control disorders in Parkinson disease: a multicenter case-control study. Ann Neurol. 2011;69(6):986\u201396.","journal-title":"Ann Neurol"},{"issue":"1","key":"1087_CR39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.parkreldis.2013.09.006","volume":"20","author":"MB Callesen","year":"2014","unstructured":"Callesen MB, Weintraub D, Damholdt MF, Moller A. Impulsive and compulsive behaviors among Danish patients with Parkinson\u2019s disease: prevalence, depression, and personality. Parkinsonism Relat Disord. 2014;20(1):22\u20136.","journal-title":"Parkinsonism Relat Disord"},{"issue":"13","key":"1087_CR40","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1002\/mds.23247","volume":"25","author":"A Djamshidian","year":"2010","unstructured":"Djamshidian A, Jha A, O\u2019Sullivan SS, Silveira-Moriyama L, Jacobson C, Brown P, et al. Risk and learning in impulsive and nonimpulsive patients with Parkinson\u2019s disease. Mov Disord. 2010;25(13):2203\u201310.","journal-title":"Mov Disord"},{"issue":"11","key":"1087_CR41","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/npp.2010.84","volume":"35","author":"CR Housden","year":"2010","unstructured":"Housden CR, O\u2019Sullivan SS, Joyce EM, Lees AJ, Roiser JP. Intact reward learning but elevated delay discounting in Parkinson\u2019s disease patients with impulsive-compulsive spectrum behaviors. Neuropsychopharmacology. 2010;35(11):2155\u201364.","journal-title":"Neuropsychopharmacology"},{"issue":"5703","key":"1087_CR42","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1126\/science.1102941","volume":"306","author":"MJ Frank","year":"2004","unstructured":"Frank MJ, Seeberger LC, O\u2019reilly RC. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science. 2004;306(5703):1940\u20133.","journal-title":"Science"},{"issue":"4","key":"1087_CR43","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00213-009-1697-y","volume":"207","author":"V Voon","year":"2010","unstructured":"Voon V, Reynolds B, Brezing C, Gallea C, Skaljic M, Ekanayake V, et al. Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology. 2010;207(4):645\u201359.","journal-title":"Psychopharmacology"},{"issue":"5","key":"1087_CR44","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1162\/jocn.2009.21227","volume":"22","author":"R Cools","year":"2010","unstructured":"Cools R, Rogers R, Barker RA, Robbins TW. Top-down attentional control in Parkinson\u2019s disease: salient considerations. J Cogn Neurosci. 2010;22(5):848\u201359.","journal-title":"J Cogn Neurosci"},{"issue":"Pt 9","key":"1087_CR45","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1093\/brain\/awp094","volume":"132","author":"N Bodi","year":"2009","unstructured":"Bodi N, Keri S, Nagy H, Moustafa A, Myers CE, Daw N, et al. Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson\u2019s patients. Brain. 2009;132(Pt 9):2385\u201395.","journal-title":"Brain"},{"issue":"3","key":"1087_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032889","volume":"7","author":"A Djamshidian","year":"2012","unstructured":"Djamshidian A, O\u2019Sullivan SS, Lees A, Averbeck BB. Effects of dopamine on sensitivity to social bias in Parkinson\u2019s disease. PLoS ONE. 2012;7(3): e32889.","journal-title":"PLoS ONE"},{"issue":"1","key":"1087_CR47","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neuron.2009.12.027","volume":"65","author":"V Voon","year":"2010","unstructured":"Voon V, Pessiglione M, Brezing C, Gallea C, Fernandez HH, Dolan RJ, et al. Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron. 2010;65(1):135\u201342.","journal-title":"Neuron"},{"issue":"23","key":"1087_CR48","doi-asserted-by":"publisher","first-page":"7814","DOI":"10.1523\/JNEUROSCI.4063-13.2014","volume":"34","author":"P Piray","year":"2014","unstructured":"Piray P, Zeighami Y, Bahrami F, Eissa AM, Hewedi DH, Moustafa AA. Impulse control disorders in Parkinson\u2019s disease are associated with dysfunction in stimulus valuation but not action valuation. J Neurosci. 2014;34(23):7814\u201324.","journal-title":"J Neurosci"},{"issue":"8","key":"1087_CR49","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1093\/brain\/awaa198","volume":"143","author":"DS Drew","year":"2020","unstructured":"Drew DS, Muhammed K, Baig F, Kelly M, Saleh Y, Sarangmat N, et al. Dopamine and reward hypersensitivity in Parkinson\u2019s disease with impulse control disorder. Brain. 2020;143(8):2502\u201318.","journal-title":"Brain"},{"issue":"4","key":"1087_CR50","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1037\/a0023795","volume":"125","author":"DO Claassen","year":"2011","unstructured":"Claassen DO, van den Wildenberg WP, Ridderinkhof KR, Jessup CK, Harrison MB, Wooten GF, et al. The risky business of dopamine agonists in Parkinson disease and impulse control disorders. Behav Neurosci. 2011;125(4):492\u2013500.","journal-title":"Behav Neurosci"},{"issue":"3","key":"1087_CR51","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.parkreldis.2010.12.014","volume":"17","author":"A Djamshidian","year":"2011","unstructured":"Djamshidian A, O\u2019Sullivan SS, Lees A, Averbeck BB. Stroop test performance in impulsive and non impulsive patients with Parkinson\u2019s disease. Parkinsonism Relat Disord. 2011;17(3):212\u20134.","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"1087_CR52","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1162\/jocn_a_00241","volume":"24","author":"SA Wylie","year":"2012","unstructured":"Wylie SA, Claassen DO, Huizenga HM, Schewel KD, Ridderinkhof KR, Bashore TR, et al. Dopamine agonists and the suppression of impulsive motor actions in Parkinson disease. J Cogn Neurosci. 2012;24(8):1709\u201324.","journal-title":"J Cogn Neurosci"},{"issue":"3","key":"1087_CR53","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3233\/JPD-181460","volume":"9","author":"P Barbosa","year":"2019","unstructured":"Barbosa P, Kaski D, Castro P, Lees AJ, Warner TT, Djamshidian A. Saccadic direction errors are associated with impulsive compulsive behaviours in Parkinson\u2019s disease patients. J Parkinsons Dis. 2019;9(3):625\u201330.","journal-title":"J Parkinsons Dis"},{"issue":"1718","key":"1087_CR54","doi-asserted-by":"publisher","first-page":"20160192","DOI":"10.1098\/rstb.2016.0192","volume":"372","author":"BC Coe","year":"2017","unstructured":"Coe BC, Munoz DP. Mechanisms of saccade suppression revealed in the anti-saccade task. Philos Trans R Soc Lond B Biol Sci. 2017;372(1718):20160192.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"5","key":"1087_CR55","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/hbm.21067","volume":"32","author":"Z Ye","year":"2011","unstructured":"Ye Z, Hammer A, Camara E, Munte TF. Pramipexole modulates the neural network of reward anticipation. Hum Brain Mapp. 2011;32(5):800\u201311.","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"1087_CR56","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/jnp.12026","volume":"7","author":"I Leroi","year":"2013","unstructured":"Leroi I, Barraclough M, McKie S, Hinvest N, Evans J, Elliott R, et al. Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson\u2019s disease. J Neuropsychol. 2013;7(2):306\u201325.","journal-title":"J Neuropsychol"},{"key":"1087_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.133","volume":"5","author":"J Joutsa","year":"2015","unstructured":"Joutsa J, Voon V, Johansson J, Niemela S, Bergman J, Kaasinen V. Dopaminergic function and intertemporal choice. Transl Psychiatry. 2015;5: e491.","journal-title":"Transl Psychiatry"},{"issue":"49","key":"1087_CR58","doi-asserted-by":"publisher","first-page":"16429","DOI":"10.1523\/JNEUROSCI.2516-10.2010","volume":"30","author":"M Sellitto","year":"2010","unstructured":"Sellitto M, Ciaramelli E, di Pellegrino G. Myopic discounting of future rewards after medial orbitofrontal damage in humans. J Neurosci. 2010;30(49):16429\u201336.","journal-title":"J Neurosci"},{"issue":"9","key":"1087_CR59","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/mds.25105","volume":"27","author":"A Djamshidian","year":"2012","unstructured":"Djamshidian A, O\u2019Sullivan SS, Sanotsky Y, Sharman S, Matviyenko Y, Foltynie T, et al. Decision making, impulsivity, and addictions: do Parkinson\u2019s disease patients jump to conclusions? Mov Disord. 2012;27(9):1137\u201345.","journal-title":"Mov Disord"},{"issue":"2","key":"1087_CR60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3233\/JPD-130178","volume":"3","author":"A Djamshidian","year":"2013","unstructured":"Djamshidian A, O\u2019Sullivan SS, Foltynie T, Aviles-Olmos I, Limousin P, Noyce A, et al. Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson\u2019s disease. J Parkinsons Dis. 2013;3(2):139\u201344.","journal-title":"J Parkinsons Dis"},{"issue":"9","key":"1087_CR61","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1016\/j.neuropsychologia.2011.04.026","volume":"49","author":"A Djamshidian","year":"2011","unstructured":"Djamshidian A, O\u2019Sullivan SS, Wittmann BC, Lees AJ, Averbeck BB. Novelty seeking behaviour in Parkinson\u2019s disease. Neuropsychologia. 2011;49(9):2483\u20138.","journal-title":"Neuropsychologia"},{"key":"1087_CR62","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fneur.2018.00129","volume":"9","author":"H Kataoka","year":"2018","unstructured":"Kataoka H, Sugie K. Delusional jealousy (Othello syndrome) in 67 patients with Parkinson\u2019s disease. Front Neurol. 2018;9:129.","journal-title":"Front Neurol"},{"issue":"4","key":"1087_CR63","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3233\/JPD-140366","volume":"4","author":"J Sachdeva","year":"2014","unstructured":"Sachdeva J, Harbishettar V, Barraclough M, McDonald K, Leroi I. Clinical profile of compulsive sexual behaviour and paraphilia in Parkinson\u2019s disease. J Parkinsons Dis. 2014;4(4):665\u201370.","journal-title":"J Parkinsons Dis"},{"key":"1087_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.parkreldis.2021.01.019","volume":"84","author":"JT Hinkle","year":"2021","unstructured":"Hinkle JT, Perepezko K, Mills KA, Pontone GM. Attentional dysfunction and the punding spectrum in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2021;84:23\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"1087_CR65","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jocn.2013.02.032","volume":"21","author":"AL Phu","year":"2014","unstructured":"Phu AL, Xu Z, Brakoulias V, Mahant N, Fung VS, Moore GD, et al. Effect of impulse control disorders on disability and quality of life in Parkinson\u2019s disease patients. J Clin Neurosci. 2014;21(1):63\u20136.","journal-title":"J Clin Neurosci"},{"issue":"20","key":"1087_CR66","doi-asserted-by":"publisher","first-page":"e2769","DOI":"10.1212\/WNL.0000000000010965","volume":"95","author":"BM Scott","year":"2020","unstructured":"Scott BM, Eisinger RS, Burns MR, Lopes J, Okun MS, Gunduz A, et al. Co-occurrence of apathy and impulse control disorders in Parkinson disease. Neurology. 2020;95(20):e2769\u201380.","journal-title":"Neurology"},{"issue":"6","key":"1087_CR67","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/jnnp.2009.186874","volume":"82","author":"SS O'Sullivan","year":"2011","unstructured":"O\u2019Sullivan SS, Loane CM, Lawrence AD, Evans AH, Piccini P, Lees AJ. Sleep disturbance and impulsive-compulsive behaviours in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2011;82(6):620\u20132.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1087_CR68","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2017.11.338","volume":"47","author":"JT Hinkle","year":"2018","unstructured":"Hinkle JT, Perepezko K, Rosenthal LS, Mills KA, Pantelyat A, Mari Z, et al. Markers of impaired motor and cognitive volition in Parkinson\u2019s disease: correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias. Parkinsonism Relat Disord. 2018;47:50\u20136.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"1087_CR69","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/jnnp-2014-307904","volume":"86","author":"ML Fantini","year":"2015","unstructured":"Fantini ML, Macedo L, Zibetti M, Sarchioto M, Vidal T, Pereira B, et al. Increased risk of impulse control symptoms in Parkinson\u2019s disease with REM sleep behaviour disorder. J Neurol Neurosurg Psychiatry. 2015;86(2):174\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1087_CR70","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jns.2019.01.034","volume":"398","author":"D Latella","year":"2019","unstructured":"Latella D, Maggio MG, Maresca G, Saporoso AF, Le Cause M, Manuli A, et al. Impulse control disorders in Parkinson\u2019s disease: a systematic review on risk factors and pathophysiology. J Neurol Sci. 2019;398:101\u20136.","journal-title":"J Neurol Sci"},{"issue":"1","key":"1087_CR71","doi-asserted-by":"publisher","first-page":"16893","DOI":"10.1038\/s41598-020-73756-z","volume":"10","author":"S Jesus","year":"2020","unstructured":"Jesus S, Labrador-Espinosa MA, Adarmes AD, Mendel-Del Barrio C, Martinez-Castrillo JC, Alonso-Canovas A, et al. Non-motor symptom burden in patients with Parkinson\u2019s disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort. Sci Rep. 2020;10(1):16893.","journal-title":"Sci Rep"},{"issue":"3","key":"1087_CR72","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1474-4422(17)30004-2","volume":"16","author":"V Voon","year":"2017","unstructured":"Voon V, Napier TC, Frank MJ, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M, et al. Impulse control disorders and levodopa-induced dyskinesias in Parkinson\u2019s disease: an update. Lancet Neurol. 2017;16(3):238\u201350.","journal-title":"Lancet Neurol"},{"issue":"5","key":"1087_CR73","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/ana.25581","volume":"86","author":"J Marin-Lahoz","year":"2019","unstructured":"Marin-Lahoz J, Sampedro F, Martinez-Horta S, Pagonabarraga J, Kulisevsky J. Depression as a risk factor for impulse control disorders in Parkinson disease. Ann Neurol. 2019;86(5):762\u20139.","journal-title":"Ann Neurol"},{"issue":"3","key":"1087_CR74","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/geront\/26.3.260","volume":"26","author":"SH Zarit","year":"1986","unstructured":"Zarit SH, Todd PA, Zarit JM. Subjective burden of husbands and wives as caregivers: a longitudinal study. Gerontologist. 1986;26(3):260\u20136.","journal-title":"Gerontologist"},{"issue":"2","key":"1087_CR75","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/mds.22939","volume":"25","author":"KP Roland","year":"2010","unstructured":"Roland KP, Jenkins ME, Johnson AM. An exploration of the burden experienced by spousal caregivers of individuals with Parkinson\u2019s disease. Mov Disord. 2010;25(2):189\u201393.","journal-title":"Mov Disord"},{"issue":"2","key":"1087_CR76","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/gps.2704","volume":"27","author":"I Leroi","year":"2012","unstructured":"Leroi I, Harbishettar V, Andrews M, McDonald K, Byrne EJ, Burns A. Carer burden in apathy and impulse control disorders in Parkinson\u2019s disease. Int J Geriatr Psychiatry. 2012;27(2):160\u20136.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"9","key":"1087_CR77","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/mdc3.13824","volume":"10","author":"D Johnson","year":"2023","unstructured":"Johnson D, Townsend L, David A, Askey-Jones S, Brown R, Samuel M, et al. Predictors of burden in carers of patients with impulse control behaviors in Parkinson\u2019s disease. Mov Disord Clin Pract. 2023;10(9):1360\u20137.","journal-title":"Mov Disord Clin Pract."},{"issue":"4","key":"1087_CR78","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/WCO.0b013e32826fbc8f","volume":"20","author":"V Voon","year":"2007","unstructured":"Voon V, Potenza MN, Thomsen T. Medication-related impulse control and repetitive behaviors in Parkinson\u2019s disease. Curr Opin Neurol. 2007;20(4):484\u201392.","journal-title":"Curr Opin Neurol"},{"key":"1087_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.654238","volume":"15","author":"A Augustine","year":"2021","unstructured":"Augustine A, Winstanley CA, Krishnan V. Impulse control disorders in Parkinson\u2019s disease: from bench to bedside. Front Neurosci. 2021;15: 654238.","journal-title":"Front Neurosci"},{"issue":"7","key":"1087_CR80","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/acn3.51569","volume":"9","author":"D Weintraub","year":"2022","unstructured":"Weintraub D, Posavi M, Fontanillas P, Tropea TF, Mamikonyan E, Suh E, et al. Genetic prediction of impulse control disorders in Parkinson\u2019s disease. Ann Clin Transl Neurol. 2022;9(7):936\u201349.","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"1087_CR81","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp-2017-317007","volume":"89","author":"L Ricciardi","year":"2018","unstructured":"Ricciardi L, Lambert C, De Micco R, Morgante F, Edwards M. Can we predict development of impulsive-compulsive behaviours in Parkinson\u2019s disease? J Neurol Neurosurg Psychiatry. 2018;89(5):476\u201381.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"1087_CR82","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/mp.2009.95","volume":"15","author":"A Fasano","year":"2010","unstructured":"Fasano A, Petrovic I. Insights into pathophysiology of punding reveal possible treatment strategies. Mol Psychiatry. 2010;15(6):560\u201373.","journal-title":"Mol Psychiatry"},{"key":"1087_CR83","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jocn.2019.07.069","volume":"69","author":"R Aoki","year":"2019","unstructured":"Aoki R, Shiraishi M, Mikami K, Kamo T. Deterioration of postural deformity in Parkinson\u2019s disease patients with punding and hobbyism. J Clin Neurosci. 2019;69:179\u201383.","journal-title":"J Clin Neurosci"},{"issue":"3","key":"1087_CR84","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/mds.25291","volume":"28","author":"J Bastiaens","year":"2013","unstructured":"Bastiaens J, Dorfman BJ, Christos PJ, Nirenberg MJ. Prospective cohort study of impulse control disorders in Parkinson\u2019s disease. Mov Disord. 2013;28(3):327\u201333.","journal-title":"Mov Disord"},{"key":"1087_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105918","volume":"117","author":"CB Morrow","year":"2023","unstructured":"Morrow CB, Hinkle JT, Seemiller J, Mills KA, Pontone GM. Examining the link between impulse control disorder and antidepressant use in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2023;117: 105918.","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"1087_CR86","doi-asserted-by":"publisher","first-page":"E36","DOI":"10.1176\/appi.neuropsych.11110326","volume":"24","author":"M Poletti","year":"2012","unstructured":"Poletti M, Frosini D, Pagni C, Claudio L, del Paolo D, Roberto C, et al. Alexithymia is associated with impulsivity in newly-diagnosed, drug-naive patients with Parkinson\u2019s disease: an affective risk factor for the development of impulse-control disorders? J Neuropsychiatry Clin Neurosci. 2012;24(4):E36\u20137.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"1087_CR87","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/mds.25679","volume":"29","author":"KS Goerlich-Dobre","year":"2014","unstructured":"Goerlich-Dobre KS, Probst C, Winter L, Witt K, Deuschl G, Moller B, et al. Alexithymia: an independent risk factor for impulsive-compulsive disorders in Parkinson\u2019s disease. Mov Disord. 2014;29(2):214\u201320.","journal-title":"Mov Disord"},{"issue":"7","key":"1087_CR88","doi-asserted-by":"publisher","first-page":"e675","DOI":"10.1212\/WNL.0000000000007942","volume":"93","author":"F Baig","year":"2019","unstructured":"Baig F, Kelly MJ, Lawton MA, Ruffmann C, Rolinski M, Klein JC, et al. Impulse control disorders in Parkinson disease and RBD: a longitudinal study of severity. Neurology. 2019;93(7):e675\u201387.","journal-title":"Neurology"},{"issue":"3","key":"1087_CR89","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3233\/JPD-150535","volume":"5","author":"M Sierra","year":"2015","unstructured":"Sierra M, Carnicella S, Strafella AP, Bichon A, Lhommee E, Castrioto A, et al. Apathy and impulse control disorders: yin & yang of dopamine dependent behaviors. J Parkinsons Dis. 2015;5(3):625\u201336.","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"1087_CR90","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.parkreldis.2011.10.005","volume":"18","author":"I Leroi","year":"2012","unstructured":"Leroi I, Andrews M, McDonald K, Harbishettar V, Elliott R, Byrne EJ, et al. Apathy and impulse control disorders in Parkinson\u2019s disease: a direct comparison. Parkinsonism Relat Disord. 2012;18(2):198\u2013203.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"1087_CR91","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41531-021-00253-z","volume":"7","author":"H Theis","year":"2021","unstructured":"Theis H, Probst C, Fernagut PO, van Eimeren T. Unlucky punches: the vulnerability-stress model for the development of impulse control disorders in Parkinson\u2019s disease. NPJ Parkinsons Dis. 2021;7(1):112.","journal-title":"NPJ Parkinsons Dis."},{"issue":"2","key":"1087_CR92","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","volume":"80","author":"D Weintraub","year":"2013","unstructured":"Weintraub D, Papay K, Siderowf A, Parkinson\u2019s Progression Markers Initiative. Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study. Neurology. 2013;80(2):176\u201380.","journal-title":"Neurology"},{"issue":"11","key":"1087_CR93","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1002\/mds.23821","volume":"26","author":"A Djamshidian","year":"2011","unstructured":"Djamshidian A, Cardoso F, Grosset D, Bowden-Jones H, Lees AJ. Pathological gambling in Parkinson\u2019s disease: a review of the literature. Mov Disord. 2011;26(11):1976\u201384.","journal-title":"Mov Disord"},{"issue":"3","key":"1087_CR94","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40519-019-00648-1","volume":"24","author":"I de Chazeron","year":"2019","unstructured":"de Chazeron I, Durif F, Chereau-Boudet I, Fantini ML, Marques A, Derost P, et al. Compulsive eating behaviors in Parkinson\u2019s disease. Eat Weight Disord. 2019;24(3):421\u20139.","journal-title":"Eat Weight Disord"},{"issue":"1","key":"1087_CR95","doi-asserted-by":"publisher","first-page":"10934","DOI":"10.1038\/s41598-021-90266-8","volume":"11","author":"I de Chazeron","year":"2021","unstructured":"de Chazeron I, Durif F, Lambert C, Chereau-Boudet I, Fantini ML, Marques A, et al. A case-control study investigating food addiction in Parkinson patients. Sci Rep. 2021;11(1):10934.","journal-title":"Sci Rep"},{"issue":"1","key":"1087_CR96","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1176\/appi.neuropsych.23.1.56","volume":"23","author":"LB Zahodne","year":"2011","unstructured":"Zahodne LB, Susatia F, Bowers D, Ong TL, Jacobson CEt, Okun MS, et al. Binge eating in Parkinson\u2019s disease: prevalence, correlates and the contribution of deep brain stimulation. J Neuropsychiatry Clin Neurosci. 2011;23(1):56\u201362.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"1087_CR97","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10072-022-06485-y","volume":"44","author":"M Contin","year":"2023","unstructured":"Contin M, Lopane G, Marini L, Mohamed S, Sambati L, De Massis P, et al. Screening for impulse control disorders in Parkinson\u2019s disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors. Neurol Sci. 2023;44(2):565\u201372.","journal-title":"Neurol Sci"},{"issue":"4","key":"1087_CR98","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1017\/S0317167100010489","volume":"37","author":"A Bharmal","year":"2010","unstructured":"Bharmal A, Lu C, Quickfall J, Crockford D, Suchowersky O. Outcomes of patients with Parkinson disease and pathological gambling. Can J Neurol Sci. 2010;37(4):473\u20137.","journal-title":"Can J Neurol Sci"},{"issue":"12","key":"1087_CR99","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1002\/mds.21611","volume":"22","author":"DA Gallagher","year":"2007","unstructured":"Gallagher DA, O\u2019Sullivan SS, Evans AH, Lees AJ, Schrag A. Pathological gambling in Parkinson\u2019s disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord. 2007;22(12):1757\u201363.","journal-title":"Mov Disord"},{"issue":"4","key":"1087_CR100","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.parkreldis.2011.01.009","volume":"17","author":"A Hassan","year":"2011","unstructured":"Hassan A, Bower JH, Kumar N, Matsumoto JY, Fealey RD, Josephs KA, et al. Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies. Parkinsonism Relat Disord. 2011;17(4):260\u20134.","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"1087_CR101","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/mds.27181","volume":"32","author":"R Biundo","year":"2017","unstructured":"Biundo R, Weis L, Abbruzzese G, Calandra-Buonaura G, Cortelli P, Jori MC, et al. Impulse control disorders in advanced Parkinson\u2019s disease with dyskinesia: the ALTHEA study. Mov Disord. 2017;32(11):1557\u201365.","journal-title":"Mov Disord"},{"issue":"8","key":"1087_CR102","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","volume":"85","author":"PJ Garcia-Ruiz","year":"2014","unstructured":"Garcia-Ruiz PJ, Martinez Castrillo JC, Alonso-Canovas A, Herranz Barcenas A, Vela L, Sanchez Alonso P, et al. Impulse control disorder in patients with Parkinson\u2019s disease under dopamine agonist therapy: a multicentre study. J Neurol Neurosurg Psychiatry. 2014;85(8):840\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1087_CR103","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s10072-023-07254-1","volume":"45","author":"LG Soileau","year":"2024","unstructured":"Soileau LG, Talbot NC, Storey NR, Spillers NJ, D\u2019Antoni JV, Carr PC, et al. Impulse control disorders in Parkinson\u2019s disease patients treated with pramipexole and ropinirole: a systematic review and meta-analysis. Neurol Sci. 2024;45(4):1399\u2013408.","journal-title":"Neurol Sci"},{"issue":"3","key":"1087_CR104","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/pcn.13511","volume":"77","author":"M Fusaroli","year":"2023","unstructured":"Fusaroli M, Giunchi V, Battini V, Gringeri M, Rimondini R, Menchetti M, et al. Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study. Psychiatry Clin Neurosci. 2023;77(3):160\u20137.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"3","key":"1087_CR105","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40263-021-00888-9","volume":"36","author":"M Fabbri","year":"2022","unstructured":"Fabbri M, Ferreira JJ, Rascol O. COMT inhibitors in the management of Parkinson\u2019s disease. CNS Drugs. 2022;36(3):261\u201382.","journal-title":"CNS Drugs"},{"key":"1087_CR106","first-page":"29","volume":"11","author":"L Azevedo Kauppila","year":"2021","unstructured":"Azevedo Kauppila L, Pimenta Silva D, Ferreira JJ. Clinical utility of opicapone in the management of Parkinson\u2019s disease: a short review on emerging data and place in therapy. Degener Neurol Neuromuscul Dis. 2021;11:29\u201340.","journal-title":"Degener Neurol Neuromuscul Dis."},{"issue":"1","key":"1087_CR107","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/JCP.0000000000000634","volume":"37","author":"M Etminan","year":"2017","unstructured":"Etminan M, Sodhi M, Samii A, Procyshyn RM, Guo M, Carleton BC. Risk of gambling disorder and impulse control disorder with aripiprazole, pramipexole, and ropinirole: a pharmacoepidemiologic study. J Clin Psychopharmacol. 2017;37(1):102\u20134.","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"1087_CR108","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/YIC.0000000000000194","volume":"33","author":"U Lertxundi","year":"2018","unstructured":"Lertxundi U, Hernandez R, Medrano J, Domingo-Echaburu S, Garcia M, Aguirre C. Aripiprazole and impulse control disorders: higher risk with the intramuscular depot formulation? Int Clin Psychopharmacol. 2018;33(1):56\u20138.","journal-title":"Int Clin Psychopharmacol"},{"key":"1087_CR109","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.euroneuro.2022.01.113","volume":"58","author":"LE De Wit","year":"2022","unstructured":"De Wit LE, Wilting I, Souverein PC, van der Pol P, Egberts TCG. Impulse control disorders associated with dopaminergic drugs: a disproportionality analysis using vigibase. Eur Neuropsychopharmacol. 2022;58:30\u20138.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"1087_CR110","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2165\/00023210-200923020-00005","volume":"23","author":"SS O'Sullivan","year":"2009","unstructured":"O\u2019Sullivan SS, Evans AH, Lees AJ. Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management. CNS Drugs. 2009;23(2):157\u201370.","journal-title":"CNS Drugs"},{"issue":"14","key":"1087_CR111","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJM198804073181402","volume":"318","author":"SJ Kish","year":"1988","unstructured":"Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson\u2019s disease: pathophysiologic and clinical implications. N Engl J Med. 1988;318(14):876\u201380.","journal-title":"N Engl J Med"},{"issue":"12","key":"1087_CR112","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1093\/cercor\/11.12.1136","volume":"11","author":"R Cools","year":"2001","unstructured":"Cools R, Barker RA, Sahakian BJ, Robbins TW. Enhanced or impaired cognitive function in Parkinson\u2019s disease as a function of dopaminergic medication and task demands. Cereb Cortex. 2001;11(12):1136\u201343.","journal-title":"Cereb Cortex"},{"key":"1087_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.wneu.2019.01.254","volume":"126","author":"YS Park","year":"2019","unstructured":"Park YS, Sammartino F, Young NA, Corrigan J, Krishna V, Rezai AR. Anatomic review of the ventral capsule\/ventral striatum and the nucleus accumbens to guide target selection for deep brain stimulation for obsessive-compulsive disorder. World Neurosurg. 2019;126:1\u201310.","journal-title":"World Neurosurg."},{"issue":"Suppl. 1","key":"1087_CR114","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neuropharm.2004.06.032","volume":"47","author":"G Di Chiara","year":"2004","unstructured":"Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, et al. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology. 2004;47(Suppl. 1):227\u201341.","journal-title":"Neuropharmacology"},{"issue":"11","key":"1087_CR115","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1093\/brain\/awz298","volume":"142","author":"P Barbosa","year":"2019","unstructured":"Barbosa P, Hapuarachchi B, Djamshidian A, Strand K, Lees AJ, de Silva R, et al. Lower nucleus accumbens alpha-synuclein load and D3 receptor levels in Parkinson\u2019s disease with impulsive compulsive behaviours. Brain. 2019;142(11):3580\u201391.","journal-title":"Brain"},{"key":"1087_CR116","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neubiorev.2013.11.001","volume":"38","author":"C Vriend","year":"2014","unstructured":"Vriend C, Pattij T, van der Werf YD, Voorn P, Booij J, Rutten S, et al. Depression and impulse control disorders in Parkinson\u2019s disease: two sides of the same coin? Neurosci Biobehav Rev. 2014;38:60\u201371.","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"1087_CR117","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/mds.26154","volume":"30","author":"R Biundo","year":"2015","unstructured":"Biundo R, Weis L, Facchini S, Formento-Dojot P, Vallelunga A, Pilleri M, et al. Patterns of cortical thickness associated with impulse control disorders in Parkinson\u2019s disease. Mov Disord. 2015;30(5):688\u201395.","journal-title":"Mov Disord"},{"key":"1087_CR118","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.parkreldis.2015.10.013","volume":"24","author":"A Tessitore","year":"2016","unstructured":"Tessitore A, Santangelo G, De Micco R, Vitale C, Giordano A, Raimo S, et al. Cortical thickness changes in patients with Parkinson\u2019s disease and impulse control disorders. Parkinsonism Relat Disord. 2016;24:119\u201325.","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"1087_CR119","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00415-015-7892-3","volume":"262","author":"C Pellicano","year":"2015","unstructured":"Pellicano C, Niccolini F, Wu K, O\u2019Sullivan SS, Lawrence AD, Lees AJ, et al. Morphometric changes in the reward system of Parkinson\u2019s disease patients with impulse control disorders. J Neurol. 2015;262(12):2653\u201361.","journal-title":"J Neurol"},{"issue":"21","key":"1087_CR120","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1212\/WNL.0000000000001619","volume":"84","author":"N Carriere","year":"2015","unstructured":"Carriere N, Lopes R, Defebvre L, Delmaire C, Dujardin K. Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease. Neurology. 2015;84(21):2116\u201323.","journal-title":"Neurology"},{"key":"1087_CR121","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cortex.2017.06.008","volume":"94","author":"A Tessitore","year":"2017","unstructured":"Tessitore A, Santangelo G, De Micco R, Giordano A, Raimo S, Amboni M, et al. Resting-state brain networks in patients with Parkinson\u2019s disease and impulse control disorders. Cortex. 2017;94:63\u201372.","journal-title":"Cortex"},{"issue":"5","key":"1087_CR122","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/ana.20822","volume":"59","author":"AH Evans","year":"2006","unstructured":"Evans AH, Pavese N, Lawrence AD, Tai YF, Appel S, Doder M, et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol. 2006;59(5):852\u20138.","journal-title":"Ann Neurol"},{"issue":"3","key":"1087_CR123","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0896-6273(00)81056-9","volume":"25","author":"JD Berke","year":"2000","unstructured":"Berke JD, Hyman SE. Addiction, dopamine, and the molecular mechanisms of memory. Neuron. 2000;25(3):515\u201332.","journal-title":"Neuron"},{"issue":"Pt 5","key":"1087_CR124","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1093\/brain\/awp054","volume":"132","author":"TD Steeves","year":"2009","unstructured":"Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain. 2009;132(Pt 5):1376\u201385.","journal-title":"Brain"},{"issue":"Pt 4","key":"1087_CR125","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/brain\/awr003","volume":"134","author":"SS O'Sullivan","year":"2011","unstructured":"O\u2019Sullivan SS, Wu K, Politis M, Lawrence AD, Evans AH, Bose SK, et al. Cue-induced striatal dopamine release in Parkinson\u2019s disease-associated impulsive-compulsive behaviours. Brain. 2011;134(Pt 4):969\u201378.","journal-title":"Brain"},{"issue":"19","key":"1087_CR126","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1212\/WNL.0b013e3181fc27fa","volume":"75","author":"T van Eimeren","year":"2010","unstructured":"van Eimeren T, Pellecchia G, Cilia R, Ballanger B, Steeves TD, Houle S, et al. Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology. 2010;75(19):1711\u20136.","journal-title":"Neurology"},{"issue":"3","key":"1087_CR127","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.nbd.2012.06.021","volume":"48","author":"NJ Ray","year":"2012","unstructured":"Ray NJ, Miyasaki JM, Zurowski M, Ko JH, Cho SS, Pellecchia G, et al. Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson\u2019s patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. Neurobiol Dis. 2012;48(3):519\u201325.","journal-title":"Neurobiol Dis"},{"issue":"8","key":"1087_CR128","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1002\/hbm.24068","volume":"39","author":"A Verger","year":"2018","unstructured":"Verger A, Klesse E, Chawki MB, Witjas T, Azulay JP, Eusebio A, et al. Brain PET substrate of impulse control disorders in Parkinson\u2019s disease: a metabolic connectivity study. Hum Brain Mapp. 2018;39(8):3178\u201386.","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"1087_CR129","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.nbd.2010.03.013","volume":"39","author":"R Cilia","year":"2010","unstructured":"Cilia R, Ko JH, Cho SS, van Eimeren T, Marotta G, Pellecchia G, et al. Reduced dopamine transporter density in the ventral striatum of patients with Parkinson\u2019s disease and pathological gambling. Neurobiol Dis. 2010;39(1):98\u2013104.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1087_CR130","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/jnnp-2013-305395","volume":"85","author":"V Voon","year":"2014","unstructured":"Voon V, Rizos A, Chakravartty R, Mulholland N, Robinson S, Howell NA, et al. Impulse control disorders in Parkinson\u2019s disease: decreased striatal dopamine transporter levels. J Neurol Neurosurg Psychiatry. 2014;85(2):148\u201352.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"1087_CR131","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/mds.25886","volume":"29","author":"C Vriend","year":"2014","unstructured":"Vriend C, Nordbeck AH, Booij J, van der Werf YD, Pattij T, Voorn P, et al. Reduced dopamine transporter binding predates impulse control disorders in Parkinson\u2019s disease. Mov Disord. 2014;29(7):904\u201311.","journal-title":"Mov Disord"},{"issue":"8","key":"1087_CR132","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1136\/jnnp-2015-311827","volume":"87","author":"KM Smith","year":"2016","unstructured":"Smith KM, Xie SX, Weintraub D. Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. J Neurol Neurosurg Psychiatry. 2016;87(8):864\u201370.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"1087_CR133","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1212\/WNL.0000000000000729","volume":"83","author":"K Papay","year":"2014","unstructured":"Papay K, Xie SX, Stern M, Hurtig H, Siderowf A, Duda JE, et al. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Neurology. 2014;83(9):826\u201333.","journal-title":"Neurology"},{"issue":"13","key":"1087_CR134","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1212\/WNL.0000000000001458","volume":"84","author":"JW Liang","year":"2015","unstructured":"Liang JW, Shanker VL, Groves M. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Neurology. 2015;84(13):1386\u20137.","journal-title":"Neurology"},{"issue":"1","key":"1087_CR135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029084","volume":"7","author":"XL Zhang","year":"2012","unstructured":"Zhang XL, Wang GB, Zhao LY, Sun LL, Wang J, Wu P, et al. Clonidine improved laboratory-measured decision-making performance in abstinent heroin addicts. PLoS ONE. 2012;7(1): e29084.","journal-title":"PLoS ONE"},{"issue":"10","key":"1087_CR136","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1007\/s00415-023-11814-y","volume":"270","author":"C Laurencin","year":"2023","unstructured":"Laurencin C, Timestit N, Marques A, Duchez DD, Giordana C, Meoni S, et al. Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson\u2019s disease: a multicenter, parallel, randomised, double-blind, phase 2b clinical trial. J Neurol. 2023;270(10):4851\u20139.","journal-title":"J Neurol"},{"key":"1087_CR137","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/brain\/awu117","volume":"137","author":"AA Kehagia","year":"2014","unstructured":"Kehagia AA, Housden CR, Regenthal R, Barker RA, Muller U, Rowe J, et al. Targeting impulsivity in Parkinson\u2019s disease using atomoxetine. Brain. 2014;137:1986\u201397.","journal-title":"Brain"},{"issue":"8","key":"1087_CR138","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1038\/npp.2016.18","volume":"41","author":"RJ Borchert","year":"2016","unstructured":"Borchert RJ, Rittman T, Passamonti L, Ye Z, Sami S, Jones SP, et al. Atomoxetine enhances connectivity of prefrontal networks in Parkinson\u2019s disease. Neuropsychopharmacology. 2016;41(8):2171\u20137.","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"1087_CR139","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/mds.22571","volume":"24","author":"D Weintraub","year":"2009","unstructured":"Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease. Mov Disord. 2009;24(10):1461\u20137.","journal-title":"Mov Disord"},{"issue":"3","key":"1087_CR140","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/0891988712455237","volume":"25","author":"AM Abrantes","year":"2012","unstructured":"Abrantes AM, Friedman JH, Brown RA, Strong DR, Desaulniers J, Ing E, et al. Physical activity and neuropsychiatric symptoms of Parkinson disease. J Geriatr Psychiatry Neurol. 2012;25(3):138\u201345.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"1","key":"1087_CR141","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/jnnp-2018-318942","volume":"90","author":"JY Lee","year":"2019","unstructured":"Lee JY, Jeon B, Koh SB, Yoon WT, Lee HW, Kwon OD, et al. Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial. J Neurol Neurosurg Psychiatry. 2019;90(1):30\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1087_CR142","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/archneurol.2009.294","volume":"67","author":"CA Rabinak","year":"2010","unstructured":"Rabinak CA, Nirenberg MJ. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol. 2010;67(1):58\u201363.","journal-title":"Arch Neurol"},{"issue":"4","key":"1087_CR143","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s13311-020-00875-w","volume":"17","author":"D Weintraub","year":"2020","unstructured":"Weintraub D. Management of psychiatric disorders in Parkinson\u2019s disease\u202f: neurotherapeutics - movement disorders therapeutics. Neurotherapeutics. 2020;17(4):1511\u201324.","journal-title":"Neurotherapeutics"},{"key":"1087_CR144","volume":"2015","author":"A Djamshidian","year":"2015","unstructured":"Djamshidian A, Poewe W, Hogl B. Impact of impulse control disorders on sleep-wake regulation in Parkinson\u2019s disease. Parkinsons Dis. 2015;2015: 970862.","journal-title":"Parkinsons Dis"},{"issue":"16","key":"1087_CR145","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1212\/WNL.0b013e3182516244","volume":"78","author":"IH Richard","year":"2012","unstructured":"Richard IH, McDermott MP, Kurlan R, Lyness JM, Como PG, Pearson N, et al. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology. 2012;78(16):1229\u201336.","journal-title":"Neurology"},{"issue":"2","key":"1087_CR146","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","volume":"34","author":"K Seppi","year":"2019","unstructured":"Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, et al. Update on treatments for nonmotor symptoms of Parkinson\u2019s disease: an evidence-based medicine review. Mov Disord. 2019;34(2):180\u201398.","journal-title":"Mov Disord"},{"issue":"Pt 5","key":"1087_CR147","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/brain\/aws078","volume":"135","author":"E Lhommee","year":"2012","unstructured":"Lhommee E, Klinger H, Thobois S, Schmitt E, Ardouin C, Bichon A, et al. Subthalamic stimulation in Parkinson\u2019s disease: restoring the balance of motivated behaviours. Brain. 2012;135(Pt 5):1463\u201377.","journal-title":"Brain"},{"issue":"3","key":"1087_CR148","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/mdc3.12416","volume":"4","author":"P Barbosa","year":"2017","unstructured":"Barbosa P, Lees AJ, Magee C, Djamshidian A, Warner TT. A retrospective evaluation of the frequency of impulsive compulsive behaviors in Parkinson\u2019s disease patients treated with continuous waking day apomorphine pumps. Mov Disord Clin Pract. 2017;4(3):323\u20138.","journal-title":"Mov Disord Clin Pract."},{"issue":"4","key":"1087_CR149","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/WNF.0000000000000091","volume":"38","author":"A Todorova","year":"2015","unstructured":"Todorova A, Samuel M, Brown RG, Chaudhuri KR. Infusion therapies and development of impulse control disorders in advanced Parkinson disease: clinical experience after 3 years\u2019 follow-up. Clin Neuropharmacol. 2015;38(4):132\u20134.","journal-title":"Clin Neuropharmacol"},{"key":"1087_CR150","doi-asserted-by":"crossref","unstructured":"Barbosa PM, Djamshidian A, O'Sullivan SS, de Pablo-Fernandez E, Korlipara P, Morris HR, et al. The long-term outcome of impulsive compulsive behaviours in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2019;90(11):1288\u20139.","DOI":"10.1136\/jnnp-2018-319891"},{"issue":"5","key":"1087_CR151","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.parkreldis.2010.02.006","volume":"16","author":"M Sohtaoglu","year":"2010","unstructured":"Sohtaoglu M, Demiray DY, Kenangil G, Ozekmekci S, Erginoz E. Long term follow-up of Parkinson\u2019s disease patients with impulse control disorders. Parkinsonism Relat Disord. 2010;16(5):334\u20137.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"1087_CR152","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/mds.21770","volume":"23","author":"E Mamikonyan","year":"2008","unstructured":"Mamikonyan E, Siderowf AD, Duda JE, Potenza MN, Horn S, Stern MB, et al. Long-term follow-up of impulse control disorders in Parkinson\u2019s disease. Mov Disord. 2008;23(1):75\u201380.","journal-title":"Mov Disord"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01087-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-024-01087-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01087-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T16:37:27Z","timestamp":1715877447000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-024-01087-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,13]]},"references-count":152,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1087"],"URL":"https:\/\/doi.org\/10.1007\/s40263-024-01087-y","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,13]]},"assertion":[{"value":"17 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by University of Innsbruck and Medical University of Innsbruck.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Federico Carbone and Atbin Djamshidian have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"AD: concept and design of the work, project organisation, writing of the first draft, review and critique. FC: concept and design of the work, project organisation, writing of the first draft, review and critique. All authors have read and approved the final version and agree to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}